Abstract
Aggrecan is a major matrix component of articular cartilage, and its dysregulated proteolysis is a crucial event in the pathogenesis of arthritis. Aggrecanases, members of ADAMTS family, play a pivotal role in aggrecan degradation with ADAMTS-4 and ADAMTS-5 being key enzymes. Cleavage events mediated by ADAMTSs are highly specific and very well characterized; therefore, it is possible to investigate aggrecanolysis by using antibodies reacting with the new N- and C-termini of the cleavage products (neoepitope antibodies). Here, we present a method for analyzing dynamic aggrecanolysis by Western blotting using neoepitope antibodies in combination with antibodies against total aggrecan fragments. The protocol is robust and has a broad application for investigation of aggrecanase activity in vitro and ex vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Doege KJ, Sasaki M, Kimura T et al (1991) Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan: human-specific repeats, and additional alternatively spliced forms. J Biol Chem 266:894–902
Kiani C, Chen L, Wu YJ et al (2002) Structure and function of aggrecan. Cell Res 12:19–32
Little CB, Hughes CE, Curtis CL et al (2002) Matrix metalloproteinases are involved in C terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol 21:271–288
Lang A, Horler D, Baici A (2000) The relative importance of cysteine peptidases in osteoarthritis. J Rheumatol 27:1970–1979
Konttinen YT, Mandelin J, Li TF et al (2002) Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum 46:953–960
Fosang AJ, Last K, Neame PJ et al (1993) Collagenase, plasmin and urokinase-type plasminogen activator cleave the aggrecan interglobular domain. Orthop Trans 17:848–849
Mok MT, Ilic MZ, Handley CJ et al (1992) Cleavage of proteoglycan aggregate by leucocyte elastase. Arch Biochem Biophys 292:442–447
Handley CJ, Tuck Mok M, Ilic MZ et al (2001) Cathepsin D cleaves aggrecan at unique sites within the interglobular domain and chondroitin sulfate attachment regions that are also cleaved when cartilage is maintained at acid pH. Matrix Biol 20:543–553
Sandy JD, Neame PJ, Boynton RE et al (1991) Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 266:8683–8685
Barry FP, Gaw JU, Young CN et al (1992) Hyaluronan binding region of aggrecan from pig laryngeal cartilage. Amino acid sequence, analysis of N-linked oligosaccharides and location of the keratan sulphate. Biochem J 286:761–769
Little CB, Meeker CT, Golub SB et al (2007) Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest 117:1627–1636
Flannery CR, Lark MW, Sandy JD (1992) Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem 267:1008–1014
Struglics A, Hansson M (2010) Calpain is involved in C-terminal truncation of human aggrecan. Biochem J 430:531–538
Sandy JD, Flannery CR, Neame PJ et al (1992) The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89:1512–1516
Lohmander LS, Neame PJ, Sandy JD (1993) The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 36:1214–1222
Ilic MZ, Handley CJ, Robinson HC et al (1992) Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 294:115–122
Tortorella MD, Burn TC, Pratta MA et al (1999) Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284:1664–1666
Abbaszade I, Liu RQ, Yang F et al (1999) Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274:23443–22350
Hughes CE, Caterson B, Fosang AJ et al (1995) Monoclonal antibodies that specifically recognize neoepitope sequences generated by ‘aggrecanase’ and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 305:799–804
Fosang AJ, Last K, Stanton H et al (2010) Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan. Methods Mol Biol 622:312–347
Tortorella MD, Pratta M, Liu RQ et al (2000) Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 275:18566–18573
Tortorella MD, Liu RQ, Burn T et al (2002) Characterization of human aggrecanase 2 (ADAMTS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 21:499–511
Struglics A, Larsson S, Pratta M et al (2006) Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase and matrix metalloproteinase generated aggrecan fragments. Osteoarthr Cartil 14:101–113
Sandy JD, Thompson V, Doege K et al (2000) The intermediates of aggrecanase- dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1. Biochem J 351:161–166
Ilic MZ, Robinson HC, Handley CJ (1998) Characterization of aggrecan retained and lost from the extracellular matrix of articular cartilage. Involvement of carboxyl-terminal processing in the catabolism of aggrecan. J Biol Chem 273:17451–17458
Swearingen CA, Carpenter JW, Siegel R et al (2010) Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine. Osteoarthr Cartil 18:1150–1158
Dufield DR, Nemirovskiy OV, Jennings MG et al (2010) An immunoaffinity LC/MS/MS assay for detection of endogenous aggrecan fragments in biological fluids. Use as a biomarker for aggrecanase activity and cartilage degradation. Anal Biochem 406:113–123
Yamamoto K, Troeberg L, Scilabra SD et al (2013) LRP-1-mediated endocytosis regulates extra- cellular activity of ADAMTS-5 in articular cartilage. FASEB J 27:511–521
Yamamoto K, Owen K, Parker AE et al (2014) Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding. J Biol Chem 289:6462–6474
Hascall VC, Sajdera SW (1969) Protein-polysaccharide complex from bovine nasal cartilage. The function of glycoprotein in the formation of aggregates. J Biol Chem 244:2384–2396
Gendron C, Kashiwagi M, Lim NH et al (2007) Proteolytic activities of human ADAMTS-5. Comparative studies with ADAMTS-4. J Biol Chem 282:18294–18306
Kashiwagi M, Enghild JJ, Gendron C et al (2004) Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 279:10109–10119
Caterson B, Christner JE, Baker JR et al (1985) Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc 44:386–393
Stanton H, Golub SB, Rogerson FM et al (2011) Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage. Nat Protoc 6:388–404
Acknowledgments
SS is supported by the Wellcome Trust Institutional Strategic Support Fund’s Faculty Fellowship Scheme (ISSF) (Imperial College London). KY is supported by the Versus Arthritis UK Career Development Fellowship Scheme (21447). The authors thank Dr. Prof. Hideaki Nagase for his critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Santamaria, S., Yamamoto, K. (2020). Analysis of Aggrecanase Activity Using Neoepitope Antibodies. In: Apte, S. (eds) ADAMTS Proteases. Methods in Molecular Biology, vol 2043. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9698-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9698-8_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9697-1
Online ISBN: 978-1-4939-9698-8
eBook Packages: Springer Protocols